Perera Tarique D, Coplan Jeremy D, Lisanby Sarah H, Lipira Cecilia M, Arif Mohamed, Carpio Cristina, Spitzer Gila, Santarelli Luca, Scharf Bruce, Hen Rene, Rosoklija Gorazd, Sackeim Harold A, Dwork Andrew J
Department of Biological Psychiatry, New York State Psychiatric Institute New York, New York 10032, USA.
J Neurosci. 2007 May 2;27(18):4894-901. doi: 10.1523/JNEUROSCI.0237-07.2007.
New neurons are generated in the adult hippocampus of many species including rodents, monkeys, and humans. Conditions associated with major depression, such as social stress, suppress hippocampal neurogenesis in rodents and primates. In contrast, all classes of antidepressants stimulate neuronal generation, and the behavioral effects of these medications are abolished when neurogenesis is blocked. These findings generated the hypothesis that induction of neurogenesis is a necessary component in the mechanism of action of antidepressant treatments. To date, the effects of antidepressants on newborn neurons have been reported only in rodents and tree shrews. This study examines whether neurogenesis is increased in nonhuman primates after antidepressant treatment. Adult monkeys received repeated electroconvulsive shock (ECS), which is the animal analog of electroconvulsive therapy (ECT), the most effective short-term antidepressant. Compared with control conditions, ECS robustly increased precursor cell proliferation in the subgranular zone (SGZ) of the dentate gyrus in the monkey hippocampus. A majority of these precursors differentiated into neurons or endothelial cells, while a few matured into glial cells. The ECS-mediated induction of cell proliferation and neurogenesis was accompanied by increased immunoreactivity for the neuroprotective gene product BCL2 (B cell chronic lymphocytic lymphoma 2) in the SGZ. The ECS interventions were not accompanied by increased hippocampal cell death or injury. This study demonstrates that ECS is capable of inducing neurogenesis in the nonhuman primate hippocampus and supports the possibility that antidepressant interventions produce similar alterations in the human brain.
在包括啮齿动物、猴子和人类在内的许多物种的成年海马体中会生成新的神经元。与重度抑郁症相关的状况,如社会压力,会抑制啮齿动物和灵长类动物海马体中的神经发生。相比之下,所有类型的抗抑郁药都会刺激神经元生成,而当神经发生被阻断时,这些药物的行为效应就会消失。这些发现催生了一个假说,即神经发生的诱导是抗抑郁治疗作用机制中的一个必要组成部分。迄今为止,抗抑郁药对新生神经元的影响仅在啮齿动物和树鼩中有所报道。本研究探讨了抗抑郁治疗后非人灵长类动物的神经发生是否会增加。成年猴子接受反复的电惊厥休克(ECS),这是电惊厥治疗(ECT)的动物模拟形式,ECT是最有效的短期抗抑郁药。与对照条件相比,ECS显著增加了猴子海马体齿状回颗粒下区(SGZ)中前体细胞的增殖。这些前体细胞中的大多数分化为神经元或内皮细胞,少数成熟为神经胶质细胞。ECS介导的细胞增殖和神经发生诱导伴随着SGZ中神经保护基因产物BCL2(B细胞慢性淋巴细胞性白血病2)免疫反应性的增加。ECS干预并未伴随着海马体细胞死亡或损伤的增加。本研究表明,ECS能够在非人灵长类动物海马体中诱导神经发生,并支持抗抑郁干预在人脑中产生类似改变的可能性。